BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Health and Human Services, Department of · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
This notice is not accepting responses.
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Not listed
- Posted
- Apr 26, 2026
- Solicitation
- 75A50126C00005
- Set-aside
- None listed
- Place of performance
- Minneapolis, MN, USA
- Contracting office
- BARDA - ASPR / DAAPPO / BARDA DCMA · WASHINGTON · DC
- Source
- SAM.gov · updated May 9, 2026
Description
The purpose of the proposed Contract is for Nebulization Therapy to Prevent and Treat Pulmonary Foam Caused by Inhaled Chemical Agents. The primary goal of the R&D effort described in this statement of work (SOW) is to generate the necessary data and information to support an initial FDA meeting to align on the regulatory strategy. The contract scope includes early-stage formulation and analytical development of the drug product; nebulizer characterization including flow rates and particle size distribution; bioanalytical development to support non-GLP studies using the proposed test article including PK, dose range finding, and chlorine exposure proof-of-concept (POC); and development of an overall regulatory strategy. This scope of work is expected to support a productive FDA engagement and advance the technical readiness level (TRL) through TRL 5 to meet minimum requirements to support various future contract vehicles. The generated data and completed non-GLP studies, along with FDA feedback, will inform work required in later development phases.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$3.35M
Middle of the pack for similar past awards
Most similar awards fall between $740,050 and $22.35M
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1AMGEN USA INC2 awards$714.70M
- 2SIGA TECHNOLOGIES, INC.1 award$624.44M
- 3EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.1 award$118.56M
- 4MAPP BIOPHARMACEUTICAL, INC.1 award$110.88M
- 5MODEX THERAPEUTICS, INC1 award$110.05M
- 6VENATORX PHARMACEUTICALS INC1 award$107.19M
- 7CROSSJECT SA1 award$104.15M
- 8LOCUS BIOSCIENCES INC1 award$73.89M
Recent examples
A few of the newest similar awards in our index.
- UNIVERSITY OF CALIFORNIA, LOS ANGELESSep 29, 2025Department of Health and Human Services$9.19MSource
- BATTELLE MEMORIAL INSTITUTESep 29, 2025Department of Health and Human Services$3.49MSource
- BATTELLE MEMORIAL INSTITUTESep 29, 2025Department of Health and Human Services$7.12MSource
- NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNOSep 29, 2025Department of Health and Human Services$3.72MSource
- PRENOSIS, INCSep 29, 2025Department of Health and Human Services$20.00MSource
- BATTELLE MEMORIAL INSTITUTESep 26, 2025Department of Health and Human Services$10.10MSource
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID 39c9f7980c97409ca9cdf6d422b5cdda.